159 related articles for article (PubMed ID: 15059919)
21. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
[TBL] [Abstract][Full Text] [Related]
22. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
Lin DL; Whitney MC; Yao Z; Keller ET
Clin Cancer Res; 2001 Jun; 7(6):1773-81. PubMed ID: 11410519
[TBL] [Abstract][Full Text] [Related]
24. p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.
Debes JD; Comuzzi B; Schmidt LJ; Dehm SM; Culig Z; Tindall DJ
Cancer Res; 2005 Jul; 65(13):5965-73. PubMed ID: 15994976
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.
Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE
Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875
[TBL] [Abstract][Full Text] [Related]
26. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
27. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
Liu P; Li S; Gan L; Kao TP; Huang H
Cancer Res; 2008 Dec; 68(24):10290-9. PubMed ID: 19074897
[TBL] [Abstract][Full Text] [Related]
28. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
Xu Q; Briggs J; Park S; Niu G; Kortylewski M; Zhang S; Gritsko T; Turkson J; Kay H; Semenza GL; Cheng JQ; Jove R; Yu H
Oncogene; 2005 Aug; 24(36):5552-60. PubMed ID: 16007214
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.
Jia L; Coetzee GA
Cancer Res; 2005 Sep; 65(17):8003-8. PubMed ID: 16140973
[TBL] [Abstract][Full Text] [Related]
30. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth.
Fu M; Rao M; Wang C; Sakamaki T; Wang J; Di Vizio D; Zhang X; Albanese C; Balk S; Chang C; Fan S; Rosen E; Palvimo JJ; Jänne OA; Muratoglu S; Avantaggiati ML; Pestell RG
Mol Cell Biol; 2003 Dec; 23(23):8563-75. PubMed ID: 14612401
[TBL] [Abstract][Full Text] [Related]
31. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG
J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687
[TBL] [Abstract][Full Text] [Related]
32. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
[TBL] [Abstract][Full Text] [Related]
33. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways.
Edwards J; Bartlett JM
BJU Int; 2005 Jun; 95(9):1327-35. PubMed ID: 15892826
[No Abstract] [Full Text] [Related]
34. Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation.
Wang Q; Zhou JL; Wang H; Ju Q; Ding Z; Zhou XL; Ge X; Shi QM; Pan C; Zhang JP; Zhang MR; Yu HM; Xu LC
Chemosphere; 2016 Sep; 158():24-9. PubMed ID: 27239967
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
Culig Z; Bartsch G; Hobisch A
Mol Cell Endocrinol; 2002 Nov; 197(1-2):231-8. PubMed ID: 12431817
[TBL] [Abstract][Full Text] [Related]
36. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
Ueda T; Bruchovsky N; Sadar MD
J Biol Chem; 2002 Mar; 277(9):7076-85. PubMed ID: 11751884
[TBL] [Abstract][Full Text] [Related]
37. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
[TBL] [Abstract][Full Text] [Related]
38. The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation.
Wang Q; Wang H; Ju Q; Ding Z; Ge X; Shi QM; Zhou JL; Zhou XL; Zhang JP; Zhang MR; Yu HM; Xu LC
Eur Cytokine Netw; 2016 Nov; 27(4):108-113. PubMed ID: 28396297
[TBL] [Abstract][Full Text] [Related]
39. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells.
Junicho A; Matsuda T; Yamamoto T; Kishi H; Korkmaz K; Saatcioglu F; Fuse H; Muraguchi A
Biochem Biophys Res Commun; 2000 Nov; 278(1):9-13. PubMed ID: 11071847
[TBL] [Abstract][Full Text] [Related]
40. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
